RESPONSE BIOMEDICAL CORP
Profile
Company Names
RESPONSE BIOMEDICAL CORP
Addresses
75TH AVENUE WEST, SUITE 1781, VANCOUVER, A1 V6P 6P2
75TH AVENUE W., SUITE 1781, VANCOUVER, A1 V6P 6P2
1781 - 75TH AVENUE W., VANCOUVER, A1 V6P6P2
Phone Numbers
604-456-6010
Entity Type:
CORPORATION
Industry:
OTHER HEALTH CARE, BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
A1
Total Amount Raised:
$19,965,190.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2013-09-26
$3,119,136.00
$4,000,000.00
$880,864.00
Equity
4
2011-12-30
$4,937,100.00
$4,937,100.00
$0.00
Equity
3
2011-11-22
$265,238.00
$1,929,000.00
$1,663,762.00
Debt
2
2010-07-28
$7,724,990.00
$7,724,990.00
$0.00
Equity
1
2009-05-21
$3,918,726.00
$7,184,331.00
$3,265,605.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD
BASTIANI
DIRECTOR
PAUL
HARRIS
EXECUTIVE OFFICER
BREVAN HOWARD LP
| BREVAN HOWARD EQUITY STRATEGIES FUND LP
| BREVAN HOWARD ASIA FUND LP
| BREVAN HOWARD EMERGING MARKETS STRATEGIES FUND LP
| BREVAN HOWARD MULTI-STRATEGY FUND, L.P.
| BREVAN HOWARD CREDIT CATALYSTS FUND, L.P.
| RESPONSE BIOMEDICAL CORP
| BREVAN HOWARD COMMODITIES STRATEGIES FUND, L.P.
| ACP POWER + ENERGY REAL ASSET FUND
| HEALTHCARE ROYALTIES TRUST
| GSO MEZZANINE FINANCE TRUST
| BREVAN HOWARD CREDIT VALUE FUND, L.P.
| BREVAN HOWARD SYSTEMATIC TRADING FUND, L.P.
| BREVAN HOWARD EMERGING MARKETS LOCAL FIXED INCOME FUND, L.P.
| FUNDAMENTAL PARTNERS MUNICIPAL TRUST
| DRC EUROPEAN REAL ESTATE DEBT FUND III L.P.
| FITZWALTER CAPITAL PARTNERS COINVEST I, LP
| FITZWALTER CAPITAL PARTNERS II, LP
ANTHONY
HOLLER
DIRECTOR
S.
WAYNE
KAY
DIRECTOR, EXECUTIVE OFFICER
JOSEPH
D.
KEEGAN
DIRECTOR
LEWIS
SHUSTER
DIRECTOR
LEWIS
J.
SHUSTER
DIRECTOR
PETER
THOMPSON
DIRECTOR
TRUBION PHARMACEUTICALS, INC
| RESPONSE BIOMEDICAL CORP
| TV ONE LLC
| TV ONE CAPITAL CORP.
| CODA THERAPEUTICS INC
| METHYLGENE INC.
| CARDIOXYL PHARMACEUTICALS INC
| PRONAI THERAPEUTICS INC
| EQDERIVATIVES, INC.
| ADAPTIMMUNE LTD
| CORVUS PHARMACEUTICALS, INC.
| PRINCIPIA BIOPHARMA INC.
| E-SCAPE BIO, INC.
| ALPINE IMMUNE SCIENCES, INC.
| CLEAVE BIOSCIENCES, INC.
| PMV PHARMACEUTICALS, INC.
| PREVAIL THERAPEUTICS INC.
| SYNTHORX, INC.
| ALPINE IMMUNE SCIENCES, INC.
| EDGEWISE THERAPEUTICS, INC.
| SILVERBACK THERAPEUTICS, INC.
| RECODE THERAPEUTICS, INC.
| ESCAPE BIO, INC.
| CRANIOVATION, INC.
| SPARROW PHARMACEUTICALS, INC.
| ALPHEUS MEDICAL, INC.
| GENNAO BIO, INC.
| TERREMOTO BIOSCIENCES, INC.
PETER
A.
THOMPSON
DIRECTOR
RESPONSE BIOMEDICAL CORP
| SILVERBACK THERAPEUTICS, INC.
| DECIBEL THERAPEUTICS, INC.
| RECODE THERAPEUTICS, INC.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED PARTNERS II, L.P.
| ORBIMED GENESIS FUND, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
DAVID
WANG
DIRECTOR
KALDOORA, INC.
| RESULTANT HEDGED EQUITY FUND, L.P.
| STRIIV, INC.
| RESPONSE BIOMEDICAL CORP
| REEF CAPITAL MANAGEMENT, LLC
| VISION FUND, L.P.
| TCW/CRATON EQUITY INVESTORS II, LP
| KONOST INC.
| ACM RESEARCH, INC.
| TCW SEPULVEDA LONG/SHORT EQUITY FUND II LP
| BEET, LLC
| TCW SEPULVEDA FOCUSED VALUE FUND, L.P.
| AEONSEMI, INC.
| BEET, INC
| NOTITIA BIOTECHNOLOGIES CO
| EDJSPORTS INC.
| POWER INNOVATION FUND, L.P.
| DOCUSMART INC.
| BIOVAXYS TECHNOLOGY CORP.
| STUDENTROOMSTAY INTERNATIONAL CORP.
| BIOINTELLISENSE, INC.
| TCW DIRECT LENDING VIII CAYMAN FEEDER LP
| TCW DIRECT LENDING VIII LLC
| TCW DIRECT LENDING PF VIII CAYMAN FEEDER LP
| TCW DIRECT LENDING PRIVATE FUND VIII LP
| BELENOS BIOSCIENCES, INC.
| AVALON ELECTRICITY FUND
| TCW STEEL CITY SENIOR LENDING BDC
JONATHAN
WANG
DIRECTOR
RESPONSE BIOMEDICAL CORP
| NORTHWOOD REAL ESTATE REIT INC.
| BONOVO ORTHOPEDICS, INC.
| NORTHWOOD REAL ESTATE CO-INVESTORS TE LP
| NORTHWOOD REAL ESTATE PARTNERS TE LP
| NORTHWOOD REAL ESTATE PARTNERS LP
| NORTHWOOD REAL ESTATE CO-INVESTORS LP
| NORTHWOOD RENAISSANCE COINVEST PARTNERS LP
| NR MANAGER LLC
| NW SOUTHEAST RETAIL HOLDINGS LLC
| NORTHWOOD RAVIN LLC
| NORTHWOOD REAL ESTATE PARTNERS 2012 LP
| NORTHWOOD NY PALACE REIT INC.
| NW OFFICE REIT HOLDINGS LLC
| NWSL INVESTMENT LLC
| NW FRESHFIELDS REIT LLC
| NW 100 BROADWAY LLC
| NW U.K. REGIONAL II (NO.2) LIMITED PARTNERSHIP
| NW U.K. REGIONAL II (NO.1) LIMITED PARTNERSHIP
| NW U.K. REGIONAL (NO.2) LIMITED PARTNERSHIP
| NW COLORADO REIT LLC
| NW PROSPECT HILL REIT LLC
| NW 230 CONGRESS STREET REIT LLC
| NWWP REIT LLC
| NW 200 SMITH STREET REIT LLC
| DOMEYARD RESEARCH, LTD.
| CB THERAPEUTICS INC.
| ORBIMED ASIA PARTNERS III, L.P.
| EOS REAL ESTATE PARTNERS II, L.P.
| EVERFIT TECHNOLOGIES INC.
| WATERSHED INFORMATICS, INC.
| EOS REAL ESTATE PARTNERS IV, L.P.
| EOS REAL ESTATE PARTNERS IV-B, L.P.
| EOS REAL ESTATE PARTNERS IV-C, L.P.
| INTRINSIC TECHNOLOGIES, INC.
| WANG CAPITAL FUND, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE
SERVICES-TESTING LABORATORIES [8734]
DECLINE TO DISCLOSE
Equity
2013-09-26
D
BIOTECHNOLOGY
SERVICES-TESTING LABORATORIES [8734]
DECLINE TO DISCLOSE
Equity
2011-12-30
D
BIOTECHNOLOGY
SERVICES-TESTING LABORATORIES [8734]
DECLINE TO DISCLOSE
Debt
2011-11-22
D
BIOTECHNOLOGY
SERVICES-TESTING LABORATORIES [8734]
$5,000,001 - $25,000,000
Equity
2010-07-28
D
BIOTECHNOLOGY
SERVICES-TESTING LABORATORIES [8734]
$5,000,001 - $25,000,000
Equity
2009-05-21
